Evidence map›Paper›PMID 27752897›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2016

Foxp3 expression in CD4

Xiao-Wen Zhu, Hai-Zhen Zhu, You-Qing Zhu, Mao-Hui Feng, Jian Qi, Zhi-Fen Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.Journal of experimental & clinical cancer research : CR · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Immunohistochemical distribution of FOXP3+ regulatory T cells in colorectal cancer patients.International journal of clinical and experimental pathology · 2018
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiao-Wen ZhuDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Hai-Zhen ZhuDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
You-Qing ZhuDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Mao-Hui FengDepartment of Surgical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Jian QiDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Zhi-Fen ChenDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zhfchen818@sina.com.
Wuhan University · CNZhongnan Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism underlying CD4

Indexed as

AdultAgedCD4-Positive T-LymphocytesColorectal NeoplasmsFemaleForkhead Transcription FactorsGene Expression Regulation, NeoplasticHumansImmunityInterleukin-10Interleukin-2 Receptor alpha SubunitLymphatic MetastasisMaleMiddle AgedSTAT3 Transcription FactorT-Lymphocytes, RegulatoryForkhead Transcription FactorsFOXP3 protein, humanInterleukin-10Interleukin-2 Receptor alpha SubunitSTAT3 protein, humanSTAT3 Transcription FactorCD4+CD25+Foxp3+ regulatory T cellscolorectal cancerFoxp3IL-10Stat3tumor immunity

Identifiers

PMID27752897
OpenAlexW2536810790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.